DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Ghanima W, Khelif A, Waage A. , et al; RITP study group.
Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial.
Lancet 2015;
385 (9978): 1653-1661
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.